184 related articles for article (PubMed ID: 29679912)
1. Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures.
Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2018 May; 58():96-100. PubMed ID: 29679912
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between valproic acid response and polymorphisms of its metabolism, transport, and receptor genes in children with focal seizures.
Feng W; Mei S; Han J; Zhu L; Yu Y; Gao B; Wu Y; Li J; Zhao Z; Fang F
Neurol Sci; 2019 Mar; 40(3):523-528. PubMed ID: 30564963
[TBL] [Abstract][Full Text] [Related]
3. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
[TBL] [Abstract][Full Text] [Related]
4. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
5. Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy.
Wang Y; Li Z
Therapie; 2020; 75(3):261-270. PubMed ID: 31474408
[TBL] [Abstract][Full Text] [Related]
6. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
[TBL] [Abstract][Full Text] [Related]
8. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
[TBL] [Abstract][Full Text] [Related]
9. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.
Sun Y; Yu J; Yuan Q; Wu X; Wu X; Hu J
Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):85. PubMed ID: 28841884
[TBL] [Abstract][Full Text] [Related]
10. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
[TBL] [Abstract][Full Text] [Related]
11. Effect of SCN1Aand SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy.
Bao Z; Li H; Hu J; Zhao R; Yan L; Zheng A
PLoS One; 2024; 19(6):e0304869. PubMed ID: 38837984
[TBL] [Abstract][Full Text] [Related]
12. Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.
Lu Y; Su Q; Li M; Dayimu A; Dai X; Wang Z; Che F; Xue F
Biomed Res Int; 2020; 2020():8096235. PubMed ID: 32185219
[TBL] [Abstract][Full Text] [Related]
13. Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China.
Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Ther Drug Monit; 2016 Dec; 38(6):738-743. PubMed ID: 27855134
[TBL] [Abstract][Full Text] [Related]
14. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
[TBL] [Abstract][Full Text] [Related]
15. Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B
Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730
[TBL] [Abstract][Full Text] [Related]
16. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
[TBL] [Abstract][Full Text] [Related]
17. Association between Genetic Polymorphism of
Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
[No Abstract] [Full Text] [Related]
18. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis.
Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604
[TBL] [Abstract][Full Text] [Related]
19. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
[TBL] [Abstract][Full Text] [Related]
20. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]